Evidence map›Paper›PMID 17935492›Full record

ReviewPigment cell research2007

ATF2 on the double - activating transcription factor and DNA damage response protein.

Anindita Bhoumik, Pablo Lopez-Bergami, Ze'ev Ronai

Open access · bronzeAbstract readReview
In one paragraph

Review in Pigment cell research, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 45 papers.

0numbers the graph read from it
0cells of the map it votes in
45citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

45 citing papers in PubMed, 98 citations in OpenAlex.

  1. Trial
  2. The Pro-Metastatic Roles of ROS.Antioxidants (Basel, Switzerland) · 2026
    Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Anindita BhoumikSignal Transduction Program, Burnham Institute for Medical Research, La Jolla, CA, USA.
Pablo Lopez-Bergami
Ze'ev Ronai
Sanford Burnham Prebys Medical Discovery Institute · US

Funding

FUNCTION OF ATF2--URE BINDING PROTEIN IN HUMAN MELANOMAR01CA051995 · NCI · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI RONAI, ZEEV A. · 1996 to 2011
$4.0M
ATF2 in melanoma development and progressionR01CA099961 · NCI · SANFORD BURNHAM PREBYS MEDICAL DISCOVERY INSTITUTE · PI RONAI, ZEEV A. · 2003 to 2012
$3.6M
UV-INDUCIBLE INHIBITION IN MELANOMAR01CA059908 · NCI · MOUNT SINAI SCHOOL OF MEDICINE OF NYU · PI RONAI, ZE'EV A · 1993 to 2005
$2.0M
MECHANISMS OF UV-RADIATION INDUCIBLE PROTEIN EXPRESSIONR29CA051995 · NCI · INSTITUTE FOR CANCER PREVENTION · PI RONAI, ZE'EV A · 1991 to 1995
–
NCI NIH HHS CA051995NCI NIH HHS CA099961NCI NIH HHS R01 CA051995NCI NIH HHS R01 CA059908NCI NIH HHS R01 CA099961
6 · The paper itself

Abstract

Signal transduction pathways play a key role in the regulation of key cellular processes, including survival and death. Growing evidence points to changes in signaling pathway that occur during skin tumor development and progression. Such changes impact the activity of downstream substrates, including transcription factors. The activating transcription factor 2 (ATF2) has been implicated in malignant and non-malignant skin tumor developments. ATF2 mediates both transcription and DNA damage control, through its phosphorylation by JNK/p38 or ATM/ATR respectively. Here, we summarize our present understanding of ATF2 regulation, function and contribution to malignant and non-malignant skin tumor development.

Indexed as

DNA DamageActivating Transcription Factor 2AnimalsHumansHypoxiaMelanomaMiceProtein IsoformsSignal TransductionSkin NeoplasmsTranscription, GeneticActivating Transcription Factor 2ATF2 protein, humanAtf2 protein, mouseProtein Isoforms

Identifiers

PMID17935492
PMCPMC2997391
OpenAlexW2036515905

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.